Corona Remedies and Ferring Pharmaceuticals collaborate on maternal health Products 2023
Corona Remedies Private Limited (CORONA), based in Ahmedabad, has entered into an agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of the global biopharmaceuticals company Ferring Pharmaceuticals headquartered in Switzerland, to commercialize unique and innovative products in the field of Maternal Health & Urology.
The collaboration between CORONA and Ferring will address unmet therapeutic requirements in maternal health and urology across India with innovative products, including a few global brands.
“We are thrilled to collaborate with Ferring, a research-driven, specialty biopharmaceutical company, to deliver world-class medicines to Indian patients. This partnership aligns with our mission and dedication to promoting health for all, stated Nirav Mehta, Promoter and Executive Director of CORONA.
Collaboration between Corona Remedies and Ferring Pharmaceuticals to improve maternal health
CORONA is a leader in women’s healthcare and has a significant presence in a variety of therapeutic areas, including anti-hypertensive, diabetes, neuropathy, hormones, pain management, dermatology, bone health, and nutritional supplements.
Numerous nations recognize Ferring’s maternal health products, which are supported by clinical studies demonstrating their efficacy and safety. The formulation of the urology products in an innovative dosage form based on Ferring’s new proprietary technology platform will offer patients with overactive bladder and erectile dysfunction greater convenience.
All of the products are one-of-a-kind in their respective classes, with differentiated formulations and drug delivery systems that offer therapeutic benefits and patient convenience. The estimated market size for these products is Rs 778.30 crore, and it is growing at a rate of 27% annually.
